The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Pediatric Drugs Market Research Report 2025
Synopsis
The market for pediatric pharmaceuticals has become an increasingly important tool in life-cycle management. However, line extensions using children’s formulations to increase patent life of existing adult dose drugs are only one of the drivers of this large, but little-studied market.
The global Pediatric Drugs market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Pediatric Drugs, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Pediatric Drugs.
Report Scope
The Pediatric Drugs market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Pediatric Drugs market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Pediatric Drugs manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Abbott Laboratories
Bayer
Boehringer Ingelheim
Bristol-Myers Squibb
Colgate Oral Pharmaceuticals
Eli Lilly
Forest Laboratories
Genentech
GlaxoSmithKline
Johnson & Johnson
MedImmune
Merck
Novartis Pharmaceuticals
Novo Nordisk
Pfizer
Pharmacia
Roche
Schering-Plough
Segment by Type
Allergy and Respiratory Drugs
Anti-Infectives
Cancer Therapies
Cardiovascular Drugs
Central Nervous System Drugs
Gastrointestinal Drugs
Hormone Drugs
Urological Drugs
Segment by Application
Hospital
Clinic
Drugstore
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Pediatric Drugs manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Pediatric Drugs in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
The market for pediatric pharmaceuticals has become an increasingly important tool in life-cycle management. However, line extensions using children’s formulations to increase patent life of existing adult dose drugs are only one of the drivers of this large, but little-studied market.
The global Pediatric Drugs market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Pediatric Drugs, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Pediatric Drugs.
Report Scope
The Pediatric Drugs market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Pediatric Drugs market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Pediatric Drugs manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Abbott Laboratories
Bayer
Boehringer Ingelheim
Bristol-Myers Squibb
Colgate Oral Pharmaceuticals
Eli Lilly
Forest Laboratories
Genentech
GlaxoSmithKline
Johnson & Johnson
MedImmune
Merck
Novartis Pharmaceuticals
Novo Nordisk
Pfizer
Pharmacia
Roche
Schering-Plough
Segment by Type
Allergy and Respiratory Drugs
Anti-Infectives
Cancer Therapies
Cardiovascular Drugs
Central Nervous System Drugs
Gastrointestinal Drugs
Hormone Drugs
Urological Drugs
Segment by Application
Hospital
Clinic
Drugstore
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Pediatric Drugs manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Pediatric Drugs in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Index1 Pediatric Drugs Market Overview
1.1 Product Overview and Scope of Pediatric Drugs
1.2 Pediatric Drugs Segment by Type
1.2.1 Global Pediatric Drugs Market Value Comparison by Type (2024-2030)
1.2.2 Allergy and Respiratory Drugs
1.2.3 Anti-Infectives
1.2.4 Cancer Therapies
1.2.5 Cardiovascular Drugs
1.2.6 Central Nervous System Drugs
1.2.7 Gastrointestinal Drugs
1.2.8 Hormone Drugs
1.2.9 Urological Drugs
1.3 Pediatric Drugs Segment by Application
1.3.1 Global Pediatric Drugs Market Value by Application: (2024-2030)
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Drugstore
1.4 Global Pediatric Drugs Market Size Estimates and Forecasts
1.4.1 Global Pediatric Drugs Revenue 2019-2030
1.4.2 Global Pediatric Drugs Sales 2019-2030
1.4.3 Global Pediatric Drugs Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Pediatric Drugs Market Competition by Manufacturers
2.1 Global Pediatric Drugs Sales Market Share by Manufacturers (2019-2024)
2.2 Global Pediatric Drugs Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Pediatric Drugs Average Price by Manufacturers (2019-2024)
2.4 Global Pediatric Drugs Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Pediatric Drugs, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Pediatric Drugs, Product Type & Application
2.7 Pediatric Drugs Market Competitive Situation and Trends
2.7.1 Pediatric Drugs Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Pediatric Drugs Players Market Share by Revenue
2.7.3 Global Pediatric Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Pediatric Drugs Retrospective Market Scenario by Region
3.1 Global Pediatric Drugs Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Pediatric Drugs Global Pediatric Drugs Sales by Region: 2019-2030
3.2.1 Global Pediatric Drugs Sales by Region: 2019-2024
3.2.2 Global Pediatric Drugs Sales by Region: 2025-2030
3.3 Global Pediatric Drugs Global Pediatric Drugs Revenue by Region: 2019-2030
3.3.1 Global Pediatric Drugs Revenue by Region: 2019-2024
3.3.2 Global Pediatric Drugs Revenue by Region: 2025-2030
3.4 North America Pediatric Drugs Market Facts & Figures by Country
3.4.1 North America Pediatric Drugs Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Pediatric Drugs Sales by Country (2019-2030)
3.4.3 North America Pediatric Drugs Revenue by Country (2019-2030)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Pediatric Drugs Market Facts & Figures by Country
3.5.1 Europe Pediatric Drugs Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Pediatric Drugs Sales by Country (2019-2030)
3.5.3 Europe Pediatric Drugs Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Pediatric Drugs Market Facts & Figures by Country
3.6.1 Asia Pacific Pediatric Drugs Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Pediatric Drugs Sales by Country (2019-2030)
3.6.3 Asia Pacific Pediatric Drugs Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Pediatric Drugs Market Facts & Figures by Country
3.7.1 Latin America Pediatric Drugs Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Pediatric Drugs Sales by Country (2019-2030)
3.7.3 Latin America Pediatric Drugs Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Pediatric Drugs Market Facts & Figures by Country
3.8.1 Middle East and Africa Pediatric Drugs Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Pediatric Drugs Sales by Country (2019-2030)
3.8.3 Middle East and Africa Pediatric Drugs Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 U.A.E
4 Segment by Type
4.1 Global Pediatric Drugs Sales by Type (2019-2030)
4.1.1 Global Pediatric Drugs Sales by Type (2019-2024)
4.1.2 Global Pediatric Drugs Sales by Type (2025-2030)
4.1.3 Global Pediatric Drugs Sales Market Share by Type (2019-2030)
4.2 Global Pediatric Drugs Revenue by Type (2019-2030)
4.2.1 Global Pediatric Drugs Revenue by Type (2019-2024)
4.2.2 Global Pediatric Drugs Revenue by Type (2025-2030)
4.2.3 Global Pediatric Drugs Revenue Market Share by Type (2019-2030)
4.3 Global Pediatric Drugs Price by Type (2019-2030)
5 Segment by Application
5.1 Global Pediatric Drugs Sales by Application (2019-2030)
5.1.1 Global Pediatric Drugs Sales by Application (2019-2024)
5.1.2 Global Pediatric Drugs Sales by Application (2025-2030)
5.1.3 Global Pediatric Drugs Sales Market Share by Application (2019-2030)
5.2 Global Pediatric Drugs Revenue by Application (2019-2030)
5.2.1 Global Pediatric Drugs Revenue by Application (2019-2024)
5.2.2 Global Pediatric Drugs Revenue by Application (2025-2030)
5.2.3 Global Pediatric Drugs Revenue Market Share by Application (2019-2030)
5.3 Global Pediatric Drugs Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Abbott Laboratories
6.1.1 Abbott Laboratories Corporation Information
6.1.2 Abbott Laboratories Description and Business Overview
6.1.3 Abbott Laboratories Pediatric Drugs Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Abbott Laboratories Pediatric Drugs Product Portfolio
6.1.5 Abbott Laboratories Recent Developments/Updates
6.2 Bayer
6.2.1 Bayer Corporation Information
6.2.2 Bayer Description and Business Overview
6.2.3 Bayer Pediatric Drugs Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Bayer Pediatric Drugs Product Portfolio
6.2.5 Bayer Recent Developments/Updates
6.3 Boehringer Ingelheim
6.3.1 Boehringer Ingelheim Corporation Information
6.3.2 Boehringer Ingelheim Description and Business Overview
6.3.3 Boehringer Ingelheim Pediatric Drugs Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Boehringer Ingelheim Pediatric Drugs Product Portfolio
6.3.5 Boehringer Ingelheim Recent Developments/Updates
6.4 Bristol-Myers Squibb
6.4.1 Bristol-Myers Squibb Corporation Information
6.4.2 Bristol-Myers Squibb Description and Business Overview
6.4.3 Bristol-Myers Squibb Pediatric Drugs Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Bristol-Myers Squibb Pediatric Drugs Product Portfolio
6.4.5 Bristol-Myers Squibb Recent Developments/Updates
6.5 Colgate Oral Pharmaceuticals
6.5.1 Colgate Oral Pharmaceuticals Corporation Information
6.5.2 Colgate Oral Pharmaceuticals Description and Business Overview
6.5.3 Colgate Oral Pharmaceuticals Pediatric Drugs Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Colgate Oral Pharmaceuticals Pediatric Drugs Product Portfolio
6.5.5 Colgate Oral Pharmaceuticals Recent Developments/Updates
6.6 Eli Lilly
6.6.1 Eli Lilly Corporation Information
6.6.2 Eli Lilly Description and Business Overview
6.6.3 Eli Lilly Pediatric Drugs Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Eli Lilly Pediatric Drugs Product Portfolio
6.6.5 Eli Lilly Recent Developments/Updates
6.7 Forest Laboratories
6.6.1 Forest Laboratories Corporation Information
6.6.2 Forest Laboratories Description and Business Overview
6.6.3 Forest Laboratories Pediatric Drugs Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Forest Laboratories Pediatric Drugs Product Portfolio
6.7.5 Forest Laboratories Recent Developments/Updates
6.8 Genentech
6.8.1 Genentech Corporation Information
6.8.2 Genentech Description and Business Overview
6.8.3 Genentech Pediatric Drugs Sales, Revenue and Gross Margin (2019-2024)
6.8.4 Genentech Pediatric Drugs Product Portfolio
6.8.5 Genentech Recent Developments/Updates
6.9 GlaxoSmithKline
6.9.1 GlaxoSmithKline Corporation Information
6.9.2 GlaxoSmithKline Description and Business Overview
6.9.3 GlaxoSmithKline Pediatric Drugs Sales, Revenue and Gross Margin (2019-2024)
6.9.4 GlaxoSmithKline Pediatric Drugs Product Portfolio
6.9.5 GlaxoSmithKline Recent Developments/Updates
6.10 Johnson & Johnson
6.10.1 Johnson & Johnson Corporation Information
6.10.2 Johnson & Johnson Description and Business Overview
6.10.3 Johnson & Johnson Pediatric Drugs Sales, Revenue and Gross Margin (2019-2024)
6.10.4 Johnson & Johnson Pediatric Drugs Product Portfolio
6.10.5 Johnson & Johnson Recent Developments/Updates
6.11 MedImmune
6.11.1 MedImmune Corporation Information
6.11.2 MedImmune Pediatric Drugs Description and Business Overview
6.11.3 MedImmune Pediatric Drugs Sales, Revenue and Gross Margin (2019-2024)
6.11.4 MedImmune Pediatric Drugs Product Portfolio
6.11.5 MedImmune Recent Developments/Updates
6.12 Merck
6.12.1 Merck Corporation Information
6.12.2 Merck Pediatric Drugs Description and Business Overview
6.12.3 Merck Pediatric Drugs Sales, Revenue and Gross Margin (2019-2024)
6.12.4 Merck Pediatric Drugs Product Portfolio
6.12.5 Merck Recent Developments/Updates
6.13 Novartis Pharmaceuticals
6.13.1 Novartis Pharmaceuticals Corporation Information
6.13.2 Novartis Pharmaceuticals Pediatric Drugs Description and Business Overview
6.13.3 Novartis Pharmaceuticals Pediatric Drugs Sales, Revenue and Gross Margin (2019-2024)
6.13.4 Novartis Pharmaceuticals Pediatric Drugs Product Portfolio
6.13.5 Novartis Pharmaceuticals Recent Developments/Updates
6.14 Novo Nordisk
6.14.1 Novo Nordisk Corporation Information
6.14.2 Novo Nordisk Pediatric Drugs Description and Business Overview
6.14.3 Novo Nordisk Pediatric Drugs Sales, Revenue and Gross Margin (2019-2024)
6.14.4 Novo Nordisk Pediatric Drugs Product Portfolio
6.14.5 Novo Nordisk Recent Developments/Updates
6.15 Pfizer
6.15.1 Pfizer Corporation Information
6.15.2 Pfizer Pediatric Drugs Description and Business Overview
6.15.3 Pfizer Pediatric Drugs Sales, Revenue and Gross Margin (2019-2024)
6.15.4 Pfizer Pediatric Drugs Product Portfolio
6.15.5 Pfizer Recent Developments/Updates
6.16 Pharmacia
6.16.1 Pharmacia Corporation Information
6.16.2 Pharmacia Pediatric Drugs Description and Business Overview
6.16.3 Pharmacia Pediatric Drugs Sales, Revenue and Gross Margin (2019-2024)
6.16.4 Pharmacia Pediatric Drugs Product Portfolio
6.16.5 Pharmacia Recent Developments/Updates
6.17 Roche
6.17.1 Roche Corporation Information
6.17.2 Roche Pediatric Drugs Description and Business Overview
6.17.3 Roche Pediatric Drugs Sales, Revenue and Gross Margin (2019-2024)
6.17.4 Roche Pediatric Drugs Product Portfolio
6.17.5 Roche Recent Developments/Updates
6.18 Schering-Plough
6.18.1 Schering-Plough Corporation Information
6.18.2 Schering-Plough Pediatric Drugs Description and Business Overview
6.18.3 Schering-Plough Pediatric Drugs Sales, Revenue and Gross Margin (2019-2024)
6.18.4 Schering-Plough Pediatric Drugs Product Portfolio
6.18.5 Schering-Plough Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Pediatric Drugs Industry Chain Analysis
7.2 Pediatric Drugs Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Pediatric Drugs Production Mode & Process
7.4 Pediatric Drugs Sales and Marketing
7.4.1 Pediatric Drugs Sales Channels
7.4.2 Pediatric Drugs Distributors
7.5 Pediatric Drugs Customers
8 Pediatric Drugs Market Dynamics
8.1 Pediatric Drugs Industry Trends
8.2 Pediatric Drugs Market Drivers
8.3 Pediatric Drugs Market Challenges
8.4 Pediatric Drugs Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
